Ezra Secures $21M to Expand AI-Powered Cancer Screening Across North America
Ezra utilizes AI to transform cancer screening, offering individuals the opportunity to detect potential health issues earlier.
Company Name: Ezra
Location: New York City, NY
Sector: Healthtech
Funding Details: Raised $21M, bringing the total to $41M. The round was led by Healthier Capital and FirstMark Capital, with participation from Allianz Life Ventures, the Schwarzman family, Lord David Prior, Gaingels, Republic, Mana Ventures, and existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson. Amir Dan Rubin joins the Board of Directors.
Purpose of Investment: To expand to 20 cities and 50 locations across North America by 2024 and advance AI technology use in imaging centers and by clinicians.
Leadership: CEO Emi Gal
Product: Ezra leverages medical imaging and AI to provide full-body cancer screening services, monitoring for potential cancer and 500+ conditions in up to 13 organs. This innovative approach aims for early detection through preventative, proactive, and ongoing screenings via Full Body MRI scans.
About Company: Ezra utilizes AI to transform cancer screening, offering individuals the opportunity to detect potential health issues earlier. Operating in multiple locations, Ezra is committed to expanding access to its groundbreaking screening services.